Followers | 244 |
Posts | 12271 |
Boards Moderated | 0 |
Alias Born | 04/05/2009 |

Tuesday, April 17, 2018 11:05:15 PM
•Coal is a less competitive as an energy source with cheaper options, like natural gas and renewable energy, on the market, says Vistra Energy CEO Curtis Morgan.
•The company shut down 4,200 megawatts of coal-fire capacity earlier this year, and has invested in a 180-megawatt solar plant in Texas.
https://www.cnbc.com/video/2018/04/16/coal-is-on-its-way-out-solar-is-in-vistra-ceo.html
"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, CEO of Harwood International
Recent VST News
- Vistra to Report Second Quarter Results on Aug. 7, 2025 • PR Newswire (US) • 07/08/2025 09:05:00 PM
- Vistra Extends Support to Flood-Impacted Communities in Central Texas • PR Newswire (US) • 07/08/2025 02:59:00 PM
- Vistra Receives Approval to Extend Operation of Perry Nuclear Plant Through 2046 • PR Newswire (US) • 07/07/2025 08:32:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2025 01:29:52 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/17/2025 03:36:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2025 01:58:54 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/05/2025 05:36:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2025 08:41:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2025 08:39:27 PM
- Vistra to Acquire Natural Gas Assets, Building on Industry-Leading Generation Portfolio to Better Serve Customers • PR Newswire (US) • 05/15/2025 09:26:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2025 09:14:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2025 08:44:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 11:00:34 AM
- Vistra Reports First Quarter 2025 Results • PR Newswire (US) • 05/07/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2025 09:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/02/2025 08:33:02 PM
- Vistra Declares Dividend on Common Stock, Series B Preferred Stock and Series C Preferred Stock • PR Newswire (US) • 05/01/2025 10:10:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/01/2025 03:12:33 PM
- Vistra to Report First Quarter Results on May 7, 2025 • PR Newswire (US) • 04/07/2025 08:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/19/2025 09:06:23 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/19/2025 09:01:13 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/19/2025 08:56:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2025 10:12:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2025 01:51:23 AM
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • BLEG • Jul 14, 2025 1:23 PM
VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM